ROBINS HARLAN S (Chief Scientific Officer) sold 7.0% of their position (106.16K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $1.85M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/18/2026ACC: 0001780851-26-000013
Officer· Chief Scientific Officer
Since Jun 2019
-106.16K
Net shares
Net seller
$1.85M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
106.16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−100K
Price / share
$17.37
Trade value
$1.74M
% of position
6.6%
6/15/2026
1.51M→1.41M
Common Stock
Direct
Shares
−6.16K
Price / share
$18.01
Trade value
$110.94K
% of position
0.4%
6/16/2026
1.41M→1.41M
Total
Net shares
−106.16K
Net value
-$1.85M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | S · Sale | −100K | $17.37 | $1.74M | 6.6% | 1.51M | 1.41M |
| Common Stock Direct | 6/16/2026 | S · Sale | −6.16K | $18.01 | $110.94K | 0.4% | 1.41M | 1.41M |
| Total | −106.16K | -$1.85M | ||||||
Derivative Transactions0
No derivative transactions reported